Pacific Biosciences Of California (PACB) Assets Average (2011 - 2026)

Pacific Biosciences Of California has reported Assets Average for 16 years, with the latest figure at $783.2 million in Q1 2026.

• For the quarter ending Q1 2026, Assets Average fell 26.15% year-over-year to $783.2 million; the trailing twelve-month figure through Mar 2026 stood at $783.2 million (down 26.15% YoY), and the FY2025 full-year result was $1.0 billion, down 32.0% from the prior year.
• Assets Average for Q1 2026 stood at $783.2 million, down from $793.6 million in the prior quarter.
• The five-year high for Assets Average was $2.0 billion in Q1 2022, with the low at $783.2 million in Q1 2026.
• Average Assets Average over 5 years is $1.5 billion, with a median of $1.7 billion recorded in 2024.
• Year-over-year, Assets Average surged 136.59% in 2022 and sank 46.96% in 2025.
• Tracing PACB's Assets Average over 5 years: stood at $1.8 billion in 2022, then rose by 1.63% to $1.8 billion in 2023, then decreased by 25.62% to $1.4 billion in 2024, then slumped by 41.44% to $793.6 million in 2025, then fell by 1.31% to $783.2 million in 2026.
• The last three Assets Average figures came in at $783.2 million (Q1 2026), $793.6 million (Q4 2025), and $814.3 million (Q3 2025), per Business Quant data.

Peer Comparison